SELLAS Life Sciences Group, Inc. SLS
13.66 USD -1.20 (-8.08%)
Regular-session close
14.21 +0.55 +4.03%
After hours · Nov 20, 7:58 PM ET
13.39 Day range 15.19
1.39 52-week range 19.15
- YTD
- +262.33%
- 1 year
- +835.62%
Next earnings
Mar 25, 2027
Expected Mar 25, 2027. Consensus EPS estimate -0.05.
Included in Essentials and up
Sign in to see Estimates and results by quarter
Analyst estimates for the coming quarters next to what the company reported.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 25, 2027 | Dec 30, 2026 | -0.05 | — | — | — |
| Nov 12, 2026 | Sep 30, 2026 | -0.05 | -0.05 | 0.00 | 0.00% |
| Aug 11, 2026 | Jun 30, 2026 | -0.045 | -0.05 | -0.01 | -11.11% |
| May 12, 2026 | Mar 31, 2026 | -0.06 | -0.05 | +0.01 | +16.67% |
| Mar 19, 2026 | Dec 31, 2025 | -0.06333 | -0.05 | +0.01 | +21.05% |
| Nov 12, 2025 | Sep 30, 2025 | -0.06333 | -0.06 | 0.00 | +5.26% |
Earnings calls
What SLS's management and analysts said on the last 11 calls
- Q3 2018 Nov 15, 2018
- Q3 2016 Nov 9, 2016
- Q2 2016 Aug 9, 2016
- Q1 2016 May 10, 2016
- Q4 2015 Mar 10, 2016
- Q3 2015 Nov 9, 2015
- Q2 2015 Aug 6, 2015
- Q1 2015 May 7, 2015
- Q4 2014 Mar 5, 2015
- Q3 2014 Nov 3, 2014
- Q2 2014 Aug 11, 2014
